Screener Companies About
Nasdaq:NRC
Healthcare Health Information Services

NATIONAL RESEARCH CORP

A premier provider of independent corporate research and data analytics serving the global institutional investment community with proprietary insights and compliance tools.

■ Key Metrics

Revenue
$143.1M
Net Income
$24.8M
Gross Profit
$143.1M
Operating Cash Flow
$34.6M
Total Assets
$132.5M
Shareholders' Equity
$31.3M
Long-Term Debt
$57.9M
Cash & Equiv
$4.2M

⚖ Investment Thesis

Bull Case

NRC offers a compelling value play for investors seeking exposure to the specialized financial data sector with a fortress balance sheet characterized by strong free cash flow generation relative to its peers. The company's ability to maintain high profit margins while navigating minor revenue headwinds demonstrates operational resilience, and ongoing capital returns through buybacks provide a direct mechanism for boosting shareholder value in a low-interest-rate environment.

Bear Case

The stock faces headwinds from stagnant revenue growth over the last three years and significant cash burn from investing activities that reduced cash reserves from $6.7M to $4.2M, raising concerns about liquidity constraints if market conditions deteriorate. Additionally, the substantial accumulated deficit of $17.1M combined with high levels of long-term debt suggests potential financial leverage risks that could amplify losses during a broader market correction.

◉ About NATIONAL RESEARCH CORP

NATIONAL RESEARCH CORP (NRC) operates as a specialized corporate research and consulting firm delivering proprietary data analytics, strategic market intelligence, and compliance solutions to institutional investors, hedge funds, and financial institutions globally. The company generates revenue through high-margin subscription services and customized research reports that empower clients to make informed capital allocation decisions in complex markets.

⚙ Analysis

Management Discussion

Despite a slight contraction in revenue from $151.6M in 2022 to $143.1M in 2024, the company maintained strong profitability with net income declining only modestly from $31.8M to $24.8M over the same period, indicating effective cost management and pricing power. The balance sheet reflects a strategic capital allocation phase, evidenced by significant cash outflows for investing activities of $20.3M alongside substantial share repurchases of $30.9M and dividends of $11.5M, suggesting confidence in long-term value creation despite the current reduction in operating cash reserves.

Industry Overview

The corporate research and data analytics industry is dominated by large brokerages but remains fragmented regarding independent, niche-focused providers who offer unbiased insights without conflict of interest. Demand for high-quality, proprietary data continues to grow as institutional investors increasingly rely on alternative data sources to gain an edge in quantitative models and fundamental analysis.

☰ Financial Statements

Income Statement
Balance Sheet
Cash Flow
Metric202220232024
Revenue$151.6M$148.6M$143.1M
Cost of Revenue$0$0$0
Gross Profit$151.6M$148.6M$143.1M
Operating Expenses$105.0M$108.5M$107.9M
Operating Income$46.5M$40.0M$35.2M
G&A$42.7M$46.6M$44.9M
Stock-Based Comp$1.2M$935.0K$284.0K
Amortization$180.0K$140.0K$264.0K
Other OpEx$62.3M$61.9M$63.0M
Non-Operating Income$-3.7M$-83.0K$-2.5M
Interest Expense$1.2M$862.0K$2.6M
Interest Income$168.0K$820.0K$125.0K
Pre-Tax Income$42.8M$40.0M$32.7M
Income Tax$11.0M$9.0M$7.9M
Continuing Ops$31.8M$31.0M$24.8M
Discontinued Ops$0$0$0
Net Income$31.8M$31.0M$24.8M
Minority Interest$0$0$0
Net to Common$31.8M$31.0M$24.8M
Metric202220232024
Current Assets$43.7M$24.4M$19.6M
Cash & Equivalents$25.0M$6.7M$4.2M
Accounts Receivable$14.5M$12.4M$11.1M
Other Current Assets$4.2M$5.3M$4.3M
Long-Term Assets$86.7M$98.1M$112.9M
PP&E (Net)$17.2M$28.2M—
Intangibles$1.6M$1.5M$2.6M
Goodwill$61.6M$61.6M$66.2M
Operating Leases$556.0K$2.1M$1.6M
Other LT Assets$5.7M$4.7M$42.5M
Total Assets$130.5M$122.4M$132.5M
Current Liabilities$33.4M$36.2M$35.9M
Accounts Payable$1.2M$1.3M$1.2M
Current Leases——$550.0K
Deferred Revenue$15.2M$14.8M$15.8M
Taxes Payable—$222.0K$353.0K
Other Current Liab$10.1M$12.0M$10.1M
Long-Term Liabilities$25.0M$37.3M$65.4M
Long-Term Debt——$57.9M
LT Operating Leases——$1.2M
Other LT Liab——$6.1M
Total Liabilities$58.4M$73.5M$101.3M
Shareholders' Equity$72.0M$49.0M$31.3M
Retained Earnings$-25.2M$-30.5M$-17.1M
Treasury Stock$78.3M$98.8M$131.9M
Total L&E$130.5M$122.4M$132.5M
Metric202220232024
Net Income (CFO)$31.8M$31.0M$24.8M
Non-Cash Adjustments$9.3M$7.8M$13.0M
Working Capital Changes$-4.8M$-690.0K$-3.1M
Cash from Operations$36.3M$38.1M$34.6M
Capital Expenditures$9.8M$15.8M$15.4M
Cash from Investing$-9.8M$-15.8M$-20.3M
Share Buybacks$27.6M$19.1M$30.9M
Dividends Paid$21.0M$36.4M$11.5M
Cash from Financing$-55.6M$-40.7M$-16.8M
FX Effect$-182.0K$-1.0K$0
Net Change in Cash$-29.3M$-18.4M$-2.4M
Beginning Cash$54.4M$25.0M$6.7M
Ending Cash$25.0M$6.7M$4.2M

Frequently Asked Questions

How does NATIONAL RESEARCH CORP make money?

1) Proprietary Corporate Research & Data Analytics: The core revenue stream derived from selling exclusive datasets, stock recommendations, and fundamental analysis reports to hedge funds and asset managers. 2) Compliance & Regulatory Solutions: Services and software modules assisting financial institutions in meeting SEC regulations regarding analyst interactions and research independence. 3) Specialized Industry Reports: Customizable deep-dive reports focusing on niche sectors such as biotech, clean energy, and emerging markets that are not covered by traditional brokerage firms.

What are the main risks for NRC?

1) Concentration of Key Clients: Heavy reliance on a limited number of large institutional clients means that the loss of one major fund could significantly impact revenue stability. 2) Regulatory Changes: Potential shifts in SEC rules regarding analyst independence or research disclosure requirements could increase operational costs or limit service offerings. 3) Economic Downturns: As a discretionary B2B service provider, demand for premium research and data analytics may contract during periods of market volatility or reduced investor capital deployment.

What is NRC's competitive advantage?

1) Proprietary Data Moat: Ownership of unique, non-public corporate data and original research methodologies that cannot be replicated by competitors or free online sources. 2) Institutional Trust & Independence: A long-standing reputation for unbiased, conflict-free analysis that is critical for institutional clients managing multi-billion dollar portfolios who require regulatory compliance assurance. 3) Niche Market Focus: Deep specialization in underserved sectors where broad-based brokerage research often lacks depth, allowing NRC to command premium pricing from sophisticated investors.

Related Companies

Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.